Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
NANOPARTICLE CHARACTERIZATION - One Size Does Not Fit All: Nanoparticle Size Analysis for Nanomedicine Applications March 30, 2016
Andrew N. Cleland, PhD, Jean-Luc Fraikin, PhD, Peter Meinhold, PhD, and Franklin Monzon, PhD, describe a new diagnostic instrument able to rapidly and accurately report detailed nanoparticle size distributions for a wide variety of nanoparticle types and concentrations in a range of different solutions.
LIPID NANOPARTICLES - EnCore(TM): Facilitating Delivery of RNAi Therapeutics to Treat Cancer March 29, 2016
Marc T. Abrams, PhD, and Bob D. Brown, PhD, explain how nanoparticle technology has the potential to enable tumor bioavailability even in the absence of a targeting ligand.
VBI Vaccines Announces Vaccine Stability Collaboration With GlaxoSmithKline February 16, 2016
VBI Vaccines Inc. has entered into a research collaboration with GlaxoSmithKline Biologicals SAto evaluate VBI’s LPV Platform, a proprietary formulation...Enable Injections & Flex Partner for Production of Wearable High-Volume Injectors February 8, 2016
Enable Injections Inc. recently announced it has entered into a product development and manufacturing partnership with Flex. As part of...ADVANCED DELIVERY DEVICES - How Data Hubs & Smart Devices Are Enabling the Rise of Therapeutic Ecosystems January 8, 2016
Stephen Allan discusses how unique collaborations between tech and biotech reflect a new paradigm in how therapeutics are being commercialized and marketed under the new pay-for-performance healthcare model.
Egalet Submits NDA for Morphine Sulfate ER Tablets December 16, 2015
Egalet Corporation recently announced the company has submitted an NDA for ARYMO ER (morphine sulfate) extended-release tablets for the management...Soligenix Announces Initiation of Pivotal Phase III Clinical Trial December 15, 2015
Soligenix, Inc. recently announced that patient enrollment has been opened for its Phase III, multicenter, randomized, double-blind, placebo-controlled study evaluating...Aptar Pharma Presents a Step Change in the Performance of DF30Plus for PMDIs Incorporating COC December 7, 2015
Aptar Pharma, a global solution provider of innovative and proven aerosol, injection, and spray delivery systems for biotech, healthcare, and...DRUG DEVICE MARKET - Joining Forces: Global Markets for Drug-Device Combinations November 19, 2015
Kevin James and Kevin Gainer of BCC Research indicate the development of the market for combination products is closely related to the drug delivery systems sector, which represents a vast area of research and the demand for sophisticated drug delivery devices behind many novel product developments.
SINGLE-USE MARKET - Rise of Single-Use Technologies & Systems in Biopharmaceuticals November 19, 2015
Kevin James and Shalini S. Dewan of BCC Research believe eliminating the risk of contamination is the greatest challenge faced by manufacturers of biopharmaceuticals, and currently, this requires high-level monitoring of critical manufacturing processes. Single-use technology aids biopharmaceutical manufacturers in overcoming this challenge by reducing or eliminating the need for sterilization between batches, thereby improving operational efficiency.
EXECUTIVE INTERVIEW - Unither Pharmaceuticals: Premeasured Dosage Forms to Improve Medication Adherence November 18, 2015
Eric Goupil, CEO Unither Pharmaceuticals, speaks frankly about medication adherence, Unither’s technology, and some of the challenges that they face today.
BioXcel Initiates Strategic Big Data Partnership With Pronutria October 23, 2015
BioXcel Corporation recently announced the initiation of a strategic big data collaboration with Pronutria Biosciences to identify diseases characterized by...Merck Millipore Adds Protein Pegylation to Portfolio of Services Through Collaboration October 8, 2015
Merck Millipore recently announced a collaboration with celares GmbH to provide pegylation services to customers developing protein-based therapeutics and biosimilars....Hemispherx Biopharma Receives New Composition of Matter Patent October 5, 2015
Hemispherx Biopharma, Inc. recently announced it received formal notice on September 21, 2015, that the European Patent Office's Examining Division...Xcelience & Powdersize Add Delta Vita Nano-Milling September 28, 2015
Xcelience and Powdersize recently announced the addition of the Netzsch Delta Vitamedia mills, a nanoparticle milling solution, to their arsenal...Lubrizol CDMO Acquisition Significantly Broadens its Capabilities September 12, 2015
The Lubrizol Corporation recently announced it has acquired Particle Sciences, a leading contract drug development and manufacturing organization with a...Downstream Processing - BioProcess International Conference Pre-Event Podcast Series September 10, 2015
Hear talk previews from Recovery & Purification + Analytcal, Quality, and Formulations speakers Characterization of Host-Cell Proteins Using Mass...NanoViricides Reports Dramatic Effects of Topical Anti-Herpes Treatment Were Reproduced Once Again August 18, 2015
NanoViricides, Inc. recently reported that the dramatic improvements in clinical symptoms associated with herpes simplex virus infection were reproduced in...INDUSTRY PERSPECTIVES - The Future of the Pharma & Biotech Industries: Your Colleague’s Perspectives June 30, 2015
The Global Formulation Report in this issue provided some interesting data on what has been happening in a number of key sectors over the past 18 months. We thought it would be intriguing to hear what some of your colleagues believe will have a significant impact on the Pharma and Biotech industries throughout the next 5 to 10 years.
TASTE-MASKING - Pharmaceutical Taste-Masking Technologies June 30, 2015
Suniket Fulzele, PhD, and Sarah Rieschl present an overview and current status of the industrial approaches and platforms used for taste-masking in oral dosage forms.
Company Profiles
Lyophilization Technology, Inc.
Lyophilization Technology, Inc. 30 Indian Drive Ivyland, PA 18974-1431 T: (215) 396-8373 F: (215) 396-8375 E: inquiry@lyo-t.com W: www.lyotechnology.com WHO...DRUG-DEVICE DEVELOPMENT - Exploring the Complexities of Drug-Device Combination Products
Jeremy Guo, Senior Vice President at WuXi Biologics, and colleagues explain that many factors need to be taken into account when producing a Drug-Device Combination Product from development testing to fill/finish and assembly.
